| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638933A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 03/29/2006 | EP1638925A1 Protease inhibitors |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638564A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1434576A4 Method of alleviating pain |
| 03/29/2006 | EP1409539B1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1284718B1 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 03/29/2006 | EP1256587B1 Novel pseudoerythromycin derivatives |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 03/29/2006 | CN1753895A Spiro-substituted pyrrolopyrimidines |
| 03/29/2006 | CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity |
| 03/29/2006 | CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/29/2006 | CN1752087A Adenine kind derivative and its synthesis method |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1751739A Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 03/29/2006 | CN1751733A Soft capsule of traditional Chinese medicine Angong Niuhuang and its prepn. method |
| 03/29/2006 | CN1751726A Fine spike acanthaceous external use medicine |
| 03/29/2006 | CN1751721A Traditional Chinese medicine soft capsule for ventilating regulating lung, and its prepn. method |
| 03/29/2006 | CN1751709A External use medicine for treating traumatic injury |
| 03/29/2006 | CN1751708A Method for extracting active component of radix scutellariae |
| 03/29/2006 | CN1751699A Sofflower injection and its prepn. method |
| 03/29/2006 | CN1751698A Application of Asarum sieboldii from north-Sichuan of Asaraceae in prepn. of medicine |
| 03/29/2006 | CN1751697A Application of single leaf Asarum sieboldii of Asaraceae in prepn. of medicine |
| 03/29/2006 | CN1247784C Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247553C 2-imino-1,3-thiazine derivs. |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247238C Chinese medicine ointment for curing hyperosteogeny, pain and numbness and its production method |
| 03/29/2006 | CN1247235C Chinese medicinal herb paste for treating traumatic injury |
| 03/29/2006 | CN1247223C Method for preparing greater celandine extract with anticancer action |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247201C Use of ribose to prevent cramping and soreness in muscles |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019022 such as ((1R)-6-fluoro-8-(methylsulfonyl)-9-{(1S)-1-[4-(trifluoromethyl)phenyl]ethyl}-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetic acid for treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018647 Patches for external use |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | US7017573 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031782A2 Salvinorin derivatives as opioid receptor ligands |
| 03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | WO2006030803A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063842 Hypogastric and/or perineal pain-relieving agent |
| 03/23/2006 | US20060063813 Organic compounds |
| 03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063768 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060062860 Use of anemonin for treating aseptic inflammations |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | DE10037121B4 Verwendung einer konzentrierten und stabilisierten antipyretischen Zusammensetzung für den tiermedizinischen Gebrauch als Zusatz zu Tiernahrung Using a concentrated and stabilized antipyretic composition for veterinary use as an additive to animal feed |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580236A1 Purinenucleoside derivative modified in 8-position and medical use thereof |